Nexus BioMed

Oncology presents a significant unmet market need. Owing to its fast track regulatory status, this is a market which offers the potential of rapid development for new therapeutics. Scientifically valid and regulatory compliant data provides a strong basis for securing licensing and partnership deals.

To successfully commercialise innovative cancer therapies takes both an in-depth knowledge and substantial experience of the field.

Nexus Biomed has both such qualities and offers a comprehensive oncology consultancy which can offer insightful advice and practical expertise in the following specialist areas:

• Identification of licensing opportunities
• Advice on appropriate drug development strategies for oncology agents
• Due diligence on behalf of companies and investors
• Market analysis to ensure the oncology portfolio of a company is appropriately valued and a full risk assessment has been conducted
• Full clinical development support including the management of phase I and II oncology studies and the selection and management of CROs for larger studies
• Feasibility assessments for planned protocols and drug development strategies
• Investigator selection
• Protocol writing
• Project Management
• Compilation of regulatory filing dossiers